Madrigal Pharmaceuticals (MDGL) EPS (Basic) (2019 - 2025)
Historic EPS (Basic) for Madrigal Pharmaceuticals (MDGL) over the last 13 years, with Q3 2025 value amounting to -$5.08.
- Madrigal Pharmaceuticals' EPS (Basic) fell 325.2% to -$5.08 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.89, marking a year-over-year increase of 4860.45%. This contributed to the annual value of -$21.9 for FY2024, which is 955.81% down from last year.
- Latest data reveals that Madrigal Pharmaceuticals reported EPS (Basic) of -$5.08 as of Q3 2025, which was down 325.2% from -$1.9 recorded in Q2 2025.
- In the past 5 years, Madrigal Pharmaceuticals' EPS (Basic) ranged from a high of -$1.9 in Q2 2025 and a low of -$7.38 during Q1 2024
- Over the past 5 years, Madrigal Pharmaceuticals' median EPS (Basic) value was -$4.23 (recorded in 2023), while the average stood at -$4.46.
- As far as peak fluctuations go, Madrigal Pharmaceuticals' EPS (Basic) plummeted by 7446.81% in 2024, and later soared by 7323.94% in 2025.
- Madrigal Pharmaceuticals' EPS (Basic) (Quarter) stood at -$3.9 in 2021, then decreased by 28.41% to -$5.01 in 2022, then decreased by 19.77% to -$6.0 in 2023, then skyrocketed by 53.48% to -$2.79 in 2024, then crashed by 81.88% to -$5.08 in 2025.
- Its last three reported values are -$5.08 in Q3 2025, -$1.9 for Q2 2025, and -$3.32 during Q1 2025.